Schedule 13D ownership disclosure

Olema Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 60862P106

Event date: 2020-11-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,743,875
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-20-000676
Form type
SC 13D
Filer
Logos Global Management LP
CIK
CIK 1792126
Filed
Dec 03, 2020
Reporting period
Nov 23, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub